Prediction of Drug–Drug Interactions by Using Profile Fingerprint Vectors and Protein Similarities
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Drug–drug interaction (DDI) is a vital problem that threatens people’s health. However, the prediction of DDIs through in-vivo experiments is not only extremely costly but also difficult as many serious side effects are hard to detect in in-vivo and in-vitro settings. The aim of this study was to assess the effectiveness of similarity-based in-silico computational DDI prediction approaches and to provide a cost effective and scalable solution to predict potential DDIs. Methods: In this study, widely known similarity-based computational DDI prediction methods were utilized to discover novel potential DDIs. More specifically, known interactions, drug targets, adverse effects, and protein similarities of drug pairs were used to construct drug fingerprints for the prediction of DDIs. Results: Using the drug interaction profile, our approach achieved an area under the curve (AUC) of 0.975 in the prediction of a potential DDI. The drug adverse effect profile and protein profile similarity-based methods resulted in AUC values of 0.685 and 0.895, respectively, in the prediction of DDIs. Conclusions: In this study, we developed a computational approach to the prediction of potential drug interactions. The performance of the similarity-based computational methods was comparatively evaluated using a comprehensive real-world DDI dataset. The evaluations showed that the drug interaction profile information is a better predictor of DDIs compared to drug adverse effects and protein similarities among DDI pairs.
Abstract
Objectives: Drug–drug interaction (DDI) is a vital problem that threatens people’s health. However, the prediction of DDIs through in-vivo experiments is not only extremely costly but also difficult as many serious side effects are hard to detect in in-vivo and in-vitro settings. The aim of this study was to assess the effectiveness of similarity-based in-silico computational DDI prediction approaches and to provide a cost effective and scalable solution to predict potential DDIs. Methods: In this study, widely known similarity-based computational DDI prediction methods were utilized to discover novel potential DDIs. More specifically, known interactions, drug targets, adverse effects, and protein similarities of drug pairs were used to construct drug fingerprints for the prediction of DDIs. Results: Using the drug interaction profile, our approach achieved an area under the curve (AUC) of 0.975 in the prediction of a potential DDI. The drug adverse effect profile and protein profile similarity-based methods resulted in AUC values of 0.685 and 0.895, respectively, in the prediction of DDIs. Conclusions: In this study, we developed a computational approach to the prediction of potential drug interactions. The performance of the similarity-based computational methods was comparatively evaluated using a comprehensive real-world DDI dataset. The evaluations showed that the drug interaction profile information is a better predictor of DDIs compared to drug adverse effects and protein similarities among DDI pairs.
참고문헌 (24)
- Vilar S, "Similarity-based modeling in largescale prediction of drug-drug interactions", Nat Protoc, 9(9), pp.2147~2163 (2014)
- "White Oak (MD): Food and Drug Administration" (2019)[URL]
- Cheng F, "Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties", J Am Med Inform Assoc, 21(e2), pp.e278~e286 (2014)
- Fowler S, "In vitro evaluation of reversible and irreversible cytochrome P450 inhibition : current status on methodologies and their utility for predicting drugdrug interactions", AAPS J, 10(2), pp.410~424 (2008)
- Jonker DM, "Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo", Pharmacol Ther, 106(1), pp.1~18 (2005)
- Ferdousi R, "Computational prediction of drug-drug interactions based on drugs functional similarities", J Biomed Inform, 70, pp.54~64 (2017)
- Tatonetti NP, "Datadriven prediction of drug effects and interactions", Sci Transl Med, 4(125), pp.125~ (2012)
- Vilar S, "Detection of drug-drug interactions by modeling interaction profile fingerprints", PLoS One, 8(3), pp.e58321~ (2013)
- Zhang W, "Predicting potential side effects of drugs by recommender methods and ensemble learning", Neurocomputing, 173, pp.979~987 (2016)
- Ayvaz S, "Toward a complete dataset of drug-drug interaction information from publicly available sources", J Biomed Inform, 55, pp.206~217 (2015)
- Noor A, "Drug-drug interaction discovery and demystification using Semantic Web technologies", J Am Med Inform Assoc, 24(3), pp.556~564 (2017)
- Vilar S, "Drug-drug interaction through molecular structure similarity analysis", J Am Med Inform Assoc, 19(6), pp.1066~1074 (2012)
- Vilar S, "State of the art and development of a drug-drug interaction large scale predictor based on 3D pharmacophoric similarity", Curr Drug Metab, 15(5), pp.490~501 (2014)
- Liu M, "Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs", J Am Med Inform Assoc, 19(e1), pp.e28~e35 (2012)
- Tatonetti NP, "A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports", J Am Med Inform Assoc, 19(1), pp.79~85 (2012)
- Harpaz R, "Statistical mining of potential drug interaction adverse effects in FDA's spontaneous reporting system", AMIA Annu Symp Proc, 2010, pp.281~285 (2010)
- Ibrahim H, "Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data", J Biomed Inform, 60, pp.294~308 (2016)
- Hudelson MG, "High confidence predictions of drug-drug interactions : predicting affinities for cytochrome P450 2C9 with multiple computational methods", J Med Chem, 51(3), pp.648~654 (2008)
- Percha B, "Biocomputing 2012", pp.410~421 (2011), World Scientific Publishing
- Tari L, "Discovering drug-drug interactions : a text-mining and reasoning approach based on properties of drug metabolism", Bioinformatics, 26(18), pp.i547~i553 (2010)
- Brown EG, "The medical dictionary for regulatory activities(MedDRA)", Drug Saf, 20(2), pp.109~117 (1999)
- Wishart DS, "DrugBank : a comprehensive resource for in silico drug discovery and exploration", Nucleic Acids Res, 34(Database), pp.D668~D672 (2006)
- Fligner MA, "A modification of the Jaccard–Tanimoto similarity index for diverse selection of chemical compounds using binary strings", Technometrics, 44(2), pp.110~119 (2002)
- Willett P, "Similarity-based approaches to virtual screening", Biochem Soc Trans, 31(Pt 3), pp.603~606 (2003)